{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nFIG. 2: SPR experimental result chart for detecting affinity of MG53 antibody and antigen protein, and K of antibody<sub>D</sub>\uff1d17.7nM\u3002\nFIG. 3: a. SPR experimental result chart for detecting affinity of MG53 and insulin receptor extracellular region, MG53 and K of insulin receptor extracellular region<sub>D</sub>8.0 nM; b. SPR experimental result chart for detecting that MG53 antibody blocks the combination of MG53 and insulin receptor extracellular region. The antibody has a Ki of 265 nM."}
{"final_json": [{"molecule_name": "MG53 antibody", "protein_target_name": "antigen protein", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "17.7", "unit": "nM"}, {"molecule_name": "MG53", "protein_target_name": "insulin receptor extracellular region", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "8.0", "unit": "nM"}, {"molecule_name": "MG53 antibody", "protein_target_name": "MG53 and insulin receptor extracellular region", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "265", "unit": "nM"}]}
{"raw_mentions": "In certain embodiments, the equilibrium dissociation constant of the MG53 inhibitor and MG53 is less than or equal to 10<sup>-6</sup>M or 10<sup>-7</sup>M.\nIn certain embodiments, the equilibrium dissociation constant of the MG53 inhibitor and MG53 is less than or equal to 10<sup>-7</sup>M or 10<sup>-8</sup>M."}
{"final_json": [{"molecule_name": "MG53 inhibitor", "protein_target_name": "MG53", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "<=10^-6", "unit": "M"}, {"molecule_name": "MG53 inhibitor", "protein_target_name": "MG53", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "<=10^-7 or <=10^-8", "unit": "M"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The dissociation constants of the 4 molecules are less than 50 mu M (see the corresponding S-shaped curve on the right, the dissociation constant is the concentration of the compound when the response value reaches half of the maximum response value), the lowest response concentration is very small and reaches the nanomolar level, which indicates that the higher the specificity of the compound for binding with MG53 protein, the better the drug potency is, and the corresponding kinetic curves are the S-shaped curves, which indicates that the 4 molecules of the compound have better kinetic characteristics.\n* Of the 4 candidate molecules, the 26 th molecule, which is worth mentioning, has the lowest response concentration of only 1.2nM and the dissociation constant of 100nM, which indicates that the molecule has very good specific binding to MG53 protein, and the SPR response curve is of the \"slow-up-slow-down\" type, which indicates that if it is used for drug administration treatment, it will show the advantages of small dosage, long drug effect, stable drug effect, and long drug administration time interval, thus having great drug formation possibility."}
{"final_json": [{"molecule_name": null, "protein_target_name": "MG53", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "<50", "unit": "mu M"}, {"molecule_name": "the 26 th molecule", "protein_target_name": "MG53", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "100", "unit": "nM"}, {"molecule_name": "the 26 th molecule", "protein_target_name": "MG53", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "1.2", "unit": "nM"}]}
